Yayınlar & Eserler

Yayın Ağı
Makaleler 17
Tümü (17)
SCI-E, SSCI, AHCI (17)
SCI-E, SSCI, AHCI, ESCI (17)
Scopus (17)
TRDizin (1)

1. Positive Effects of Oral beta-Glucan on Mucositis and Leukopenia in Colorectal Cancer Patients Receiving Adjuvant FOLFOX-4 Combination Chemotherapy

Karaca H., BOZKURT O., Ozaslan E., Baldane S., Berk V., İNANÇ M., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.15, sa.8, ss.3641-3644, 2014 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier

2. Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study

KAYA M. F., ÖZKAN M., Gunebakmaz O., Akkaya H., Kaya E. G., Akpek M., et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY , cilt.167, sa.5, ss.2306-2310, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

3. D-dimer is a marker of response to chemotherapy in patients with metastatic colorectal cancer

Inanc M., Er O., Karaca H., Berk V., ÖZKAN M., Dikilitas M., et al.
JOURNAL OF BUON , cilt.18, sa.2, ss.391-397, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

4. Concomitant chemoradiotherapy with docetaxel and cisplatin followed by consolidation chemotherapy in locally advanced unresectable non-small cell lung cancer

Eroglu C., ORHAN O., Ünal D., Dogu G. G., Karaca H., Dikilitas M., et al.
ANNALS OF THORACIC MEDICINE , cilt.8, sa.2, ss.109-115, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

5. The effect of being overweight on survival in patients with gastric cancer undergoing adjuvant chemoradiotherapy

EROGLU C., ORHAN O., KARACA H., UNAL D., DIKILITAS M., ÖZKAN M., et al.
EUROPEAN JOURNAL OF CANCER CARE , cilt.22, sa.1, ss.133-140, 2013 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma identifier

6. Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancer

Yildiz R., Benekli M., ÖZKAN M., Alkis N., Berk V., Kaplan M. A., et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.138, sa.11, ss.1845-1852, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

7. Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?

ÖZKAN M., Sivgin S., KOÇYİĞİT I., Emirogullari F., Dikilitas M., KAYNAR L., et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY , cilt.8, sa.3, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

8. Gemcitabine and Cisplatin Combination Chemotherapy in Triple Negative Metastatic Breast Cancer Previously Treated with a Taxane/Anthracycline Chemotherapy; Multicenter Experience

ÖZKAN M., Berk V., Kaplan M. A., Benekli M., Coskun U., Bilici A., et al.
NEOPLASMA , cilt.59, sa.1, ss.38-42, 2012 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier

9. Irinotecan as a Second-line Monotherapy for Small Cell Lung Cancer

Sevinc A., Kalender M. E., Altinbas M., ÖZKAN M., Dikilitas M., Camci C.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.12, sa.4, ss.1055-1059, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

10. Recovery of paraneoplastic hypercalcemia by sunitinib treatment for renal cell carcinoma: a case report and review of the literature

Karaca H., Lale A., Dikilitas M., ÖZKAN M., Er O.
MEDICAL ONCOLOGY , cilt.27, sa.3, ss.1023-1026, 2010 (SCI-Expanded, Scopus) identifier

11. The effect of education given to women with breast cancer on chemotherapy treatment on anxiety levels

Guleser G., TAŞCI S., TOKMAKÇI M., Dikilitas M., Celiksoy A., Horasan P., et al.
EUROPEAN JOURNAL OF ONCOLOGY NURSING , cilt.14, 2010 (SCI-Expanded, SSCI, Scopus) identifier identifier

12. Hypoglycemia in a Patient With Metastatic Gastrointestinal Stromal Tumor: Is Chemotherapy a Reasonable Option for Symptom Control?

Dogu G. G., Dikilitas M., ÖZKAN M., KARAHAN Ö. I., Karaca Z., Gunay N., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.20, sa.1, ss.48-51, 2010 (SCI-Expanded, Scopus, TRDizin) identifier

13. Multiple Gastrointestinal Stromal Tumors and Their Association with Other Rare Tumors: Case Report

Soyuer I., Tasdemir A., ÖZTÜRK F., GÜRSOY Ş., Artis T., Dikilitas M., et al.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , cilt.30, sa.1, ss.361-367, 2010 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

14. Triple-negative breast cancer: immunohistochemical correlation with basaloid markers and prognostic value of survivin

Dogu G. G., ÖZKAN M., ÖZTÜRK F., Dikilitaş M., Er O., ÖZTÜRK A.
MEDICAL ONCOLOGY , cilt.27, sa.1, ss.34-39, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

15. Prognostic Value of Excision Repair Cross-complementing Gene 1 Expression for Cisplatin-Based Chemotherapy in Advanced Gastric Cancer

ÖZKAN M., Akbudak I. H., DENİZ K., Dikilitas M., Dogu G. G., Berk V., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.11, sa.1, ss.181-185, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

16. Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients

Coskun U., Buyukberber S., Yaman E., Uner A., Er O., ÖZKAN M., et al.
NEOPLASMA , cilt.55, sa.1, ss.65-70, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

17. Thrombosis and cancer: Clinical, laboratuary and genetic evaluation.

ÖZKAN M., Dikilitas M., KOÇYİĞİT I., Er O., SARI İ., Dogu G., et al.
ANNALS OF ONCOLOGY , sa.17, ss.301, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 1

1. Kemik dışı Ewing sarkomu ve 99mTc MDP sintigrafisinde yaygın kemik metastazı

ABDÜLREZZAK Ü., BERK V., ERDOĞAN Z., KARACA H., DİKİLİTAŞ M., KULA M., et al.
6. Ulusal Tıbbi Onkoloji Kogresi, Türkiye, 24 - 28 Eylül 2009
Metrikler

Yayın

18

Yayın (WoS)

17

Yayın (Scopus)

17

Atıf (WoS)

323

H-İndeks (WoS)

8

Atıf (Scopus)

74

H-İndeks (Scopus)

4

Atıf (Scholar)

63

H-İndeks (Scholar)

2

Proje

2

Açık Erişim

3
BM Sürdürülebilir Kalkınma Amaçları